EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis

Adam Saleh, Shyon Parsa, Manuel Garza, Eamonn M M Quigley, Bincy P Abraham

Digestive Diseases · 2023

DOI: 10.1159/000529591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive Diseases, 2023. Verfasst von Adam Saleh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M Health Science Center, Engineering Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Considerable research supports an important role for the microbiome and/or microbiome-host immune system interactions in the pathogenesis of inflammatory bowel disease (IBD). Consequently, microbiota-modulating interventions, such as fecal microbiota transplantation (FMT), have attracted interest in the management of IBD, including ulcerative colitis (UC). Summary: While the clinical response to FMT in UC has varied between different studies, results to date may offer guidance toward optimal use of FMT. Thus, increased microbiome biodiversity, the presence of short-chain fatty acid-producing bacteria, Clostridium clusters IV and XIVa, Odoribacter splanchnicus, and reduced levels of Caudovirales bacteriophages have been identified as characteristics of the donor microbiome that predict a positive response. However, inconsistency in FMT protocol between studies confounds their interpretation, so it is currently difficult to predict response and premature to recommend FMT, in general, as a treatment for UC. Additional randomized controlled trials designed based on previous findings and employing a standardized protocol are needed to define the role of FMT in the management of UC. Key Messages: There is a well-developed rationale for the use of microbiome-modulating interventions in UC. Despite variations in study protocol and limitations in study design that confound their interpretation, FMT seems to benefit patients with UC, overall. Available data identify factors predicting FMT response and should lead to the development of optimal FMT study protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeInflammatory Bowel DiseasesHumansFecal Microbiota TransplantationFecesRemission InductionTreatment Outcome

Stichwörter der Autor:innen

Fecal microbiota transplantationInflammatory bowel diseaseMicrobiomeMicrobiotaUlcerative colitis

Autor:innen und Institutionen

  • Texas A&M Health Science Center, Engineering Medicine, Houston, Texas, USA.
  • UT Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Gastroenterology and Hepatology, Lynda K and David M Underwood Center for Digestive Disorders, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.

Zitieren

APA

Saleh, A., Parsa, S., Garza, M., Quigley, E. M. M., & Abraham, B. P. (2023). The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis. Digestive Diseases. https://doi.org/10.1159/000529591

Vancouver

Saleh A, Parsa S, Garza M, Quigley EMM, Abraham BP. The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis. Digestive Diseases. 2023. doi:10.1159/000529591

BibTeX
@article{Saleh2023,
  author = {Saleh, Adam and Parsa, Shyon and Garza, Manuel and Quigley, Eamonn M M and Abraham, Bincy P},
  title = {The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis},
  journal = {Digestive Diseases},
  year = {2023},
  doi = {10.1159/000529591}
}
Kostenlos starten →